SCHEMBL5795510

SCHEMBL5795510

O=C(O)c1nc(-c2ccc(Br)cc2)nc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 4/20 0.60
CYP1A1 P04798 2/20 0.60
CYP1A2 P05177 1/20 0.60
TSPO P30536 1/20 0.54
ABCG2 Q9UNQ0 4/20 0.52
GRM2 Q14416 1/20 0.50
TP53 P04637 3/20 0.48
ADORA3 P0DMS8 2/20 0.48
TNKS O95271 1/20 0.48
TNKS2 Q9H2K2 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
ALDH1A1 P00352 2/20 0.47
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
EGFR P00533 1/20 0.47
KDM4E B2RXH2 2/20 0.47
ABCC1 P33527 1/20 0.47
NR1H2 P55055 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7601367 0.88 ABCG2 (0.54) TSPOABCG2TP53ADORA3ALDH1A1
SCHEMBL5781008 0.88 ABCG2 (0.57) TSPOABCG2TP53ADORA3ALDH1A1
SCHEMBL16039130 0.84 MEN1 (0.62) CYP1B1CYP1A1CYP1A2ABCG2TP53
SCHEMBL16039146 0.84 CYP1A1 (0.60) CYP1B1CYP1A1CYP1A2ABCG2TP53
SCHEMBL16039656 0.84 MAPT (0.59) CYP1A2ABCG2GRM2TP53ADORA3
SCHEMBL16038378 0.84 PDE10A (0.58) ABCG2TP53ADORA3TNKSTNKS2
Dimethylamine SCHEMBL4104002 0.82 ABCG2 (0.55) CYP1A2TSPOABCG2TP53ADORA3
SCHEMBL16039610 0.80 PRNP (0.47) CYP1B1CYP1A1CYP1A2ABCG2TP53
SCHEMBL16038364 0.80 CYP3A4 (0.68) CYP1A2TP53ALDH1A1MAPTSMN1; SMN2
SCHEMBL16038183 0.80 ABCG2 (0.56) ABCG2TP53ADORA3TNKSTNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006034491-A2 PHENYL-SUBSTITUTED QUINOLINE AND QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF DIABETES BAYER PHARMACEUTICALS CORPORATION (US) 2006-03-30 WO disclosed
WO-2006034512-A2 PHENYL-SUBSTITUTED QUINOLINE AND QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF DIABETES BAYER PHARMACEUTICALS CORPORATION (US) 2006-03-30 WO disclosed